Evogene Ltd.EVGNNASDAQ
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank95
5Y CAGR+47.2%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
+47.2%/yr
Long-term compound
Percentile
P95
Near historical high
vs 5Y Ago
6.9x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 34.58% |
| Q2 2025 | -6.07% |
| Q1 2025 | -16.50% |
| Q4 2024 | 3.61% |
| Q3 2024 | -46.19% |
| Q2 2024 | -21.89% |
| Q1 2024 | -11.58% |
| Q4 2023 | -22.64% |
| Q3 2023 | 6.52% |
| Q2 2023 | 0.20% |
| Q1 2023 | 714.03% |
| Q4 2022 | -9.20% |
| Q3 2022 | -15.67% |
| Q2 2022 | -17.08% |
| Q1 2022 | -13.72% |
| Q4 2021 | -11.10% |
| Q3 2021 | -8.28% |
| Q2 2021 | -10.38% |
| Q1 2021 | 26.52% |
| Q4 2020 | -19.86% |
| Q3 2020 | 5.01% |
| Q2 2020 | -7.21% |
| Q1 2020 | -8.77% |
| Q4 2019 | -8.95% |
| Q3 2019 | 54.31% |
| Q2 2019 | -8.33% |
| Q1 2019 | -7.06% |
| Q4 2018 | -9.81% |
| Q3 2018 | -6.98% |
| Q2 2018 | -6.84% |
| Q1 2018 | -6.59% |
| Q4 2017 | -8.17% |
| Q3 2017 | -5.66% |
| Q2 2017 | -5.48% |
| Q1 2017 | -4.38% |
| Q4 2016 | -6.35% |
| Q3 2016 | -7.41% |
| Q2 2016 | 0.85% |
| Q1 2016 | -6.34% |
| Q4 2015 | 0.40% |